Novo Nordisk CEO says experimental weight loss pill could become a best-in-class drug

Amit March 08, 2024
Lars Fruergaard Jørgensen's remarks came one day after Novo Nordisk impressed investors with early-stage trial data on amycretin.
Amit

Posted by Amit

Post a Comment

0 Comments